Follow-up cohort of asthmatic patient treated with inhaled corticosteroid FRESH-PEF165-en Céline PRIBIL Follow-up cohort of asthmatic patient treated with inhaled corticosteroid OCSIGEN FRESH-PEF165-en 165 FRESH-PEF165 Céline PRIBIL GLAXOSMITHKLINE (FRANCE) Epidemiology France Portal (PEF) GLAXOSMITHKLINE (FRANCE) null Céline;PRIBIL inhaled steroids cohort Pulmonary medicine Healthcare system determinants: Use of care Healthcare system determinants Describe the conditions of use of the fluticasone and other inhaled corticosteroids in a pragmatic situation in general practice and in specialized pneumology, evaluate the severity of the asthma of patients cared for and measure the adequacy of the care with the national recommendations null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) GP section: The eligible population is defined by all of the asthmatic patients over the age of 15 years who have consulted at least twice in the previous year and in whom an inhaled corticotherapy is in progress (at least one prescription in the last six months). Patients defined as such who come to consult spontaneously for asthma during the period of inclusion will also be included. Pneumologist section:Asthmatic persons cared for in liberal pneumology present in the practice of the investigators of the study and meeting the inclusion criteria Refusal to participate and the association of the asthma with an OCPD are criteria for non-inclusion. Clinical data Participant-reported health data Health care consumption and services Probability: Stratified Through independent healthcare practitioners [1000-10000[ individuals Interview with the participant (including clinical) Observational Study Observational Study 1691 Unknown Restricted access Access on specific project only